Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Wordpress Table Plugin

American West Metals (ASX:AW1) has revealed a major copper discovery at the Storm project in Canada. Diamond drilling of a large gravity target has intersected thick intervals of copper sulphides, reports the company.

The discovery is being compared with major sediment-hosted copper systems, including the deposits of the Kalahari Copper Belt and Central African Copper Belt.

American West Metals MD Dave O’Neill said: “We are very excited to announce that the diamond drilling has had immediate success and produced spectacular results confirming the presence of a major copper system within the Storm Project.

“These outstanding results are the product of systematic and persistent exploration, and further highlight the quality and huge exploration potential of the landholding.”

Meanwhile, healthcare stock BCAL Diagnostics (ASX:BDX), which is helping develop a novel blood screening test for diagnosis and monitoring of breast cancer, is up today after some breakthrough results.

It’s reportedly a major step towards commercialisation of BCAL’s breast cancer diagnostic test, coming from the firm’s Precion US study. According to a company statement, the analysis undertaken achieved an impressive sensitivity of 90% and a specificity of 85.5%.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Wordpress Table Plugin

Victory Metals (ASX:VTM) released a maiden resource of 250Mt at a grade of 520 parts per million (ppm) rare earths – for 130,000t contained rare earths – at the North Stanmore project in WA.

Biotech Actinogen Medical (ASX:ACW) is down today, despite the company announcing a non-renounceable rights issue offer to raise roughly $10 million from eligible shareholders. 

It will raise $10m at 2.5c per share – a substantial discount to the last closing price.

Lastly, lithium explorer Tambourah Metals (ASX:TMB) will raise $3.7m at 23.5c per share – a 30.9% discount to the last closing price of TMB shares and a 13.8% discount to 10-day VWAP.